FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016967290> ?p ?o ?g. }

• W3016967290 endingPage "700" @default.
• W3016967290 startingPage "695" @default.
• W3016967290 abstract "The National Cancer Survivorship Initiative through the National Health Service (NHS) improvement in the UK started the implementation of stratified pathways of patient-initiated follow-up (PIFU) across various tumor types. Now the initiative is continued through the Living With and Beyond Cancer program by NHS England. Evidence from non-randomized studies and systematic reviews does not demonstrate a survival advantage to the long-established practice of hospital-based follow-up regimens, traditionally over 5 years. Evidence shows that patient needs are inadequately met under the traditional follow-up programs and there is therefore an urgent need to adapt pathways to the needs of patients. The assumption that hospital-based follow-up is able to detect cancer recurrences early and hence improve patient prognosis has not been validated. A recent survey demonstrates that follow-up practice across the UK varies widely, with telephone follow-up clinics, nurse-led clinics and PIFU becoming increasingly common. There are currently no completed randomized controlled trials in PIFU in gynecological malignancies, although there is a drive towards implementing PIFU. PIFU aims to individualize patient care, based on risk of recurrence and holistic needs, and optimizing resources. The British Gynaecological Cancer Society wishes to provide the gynecological oncology community with guidance and a recommendations statement regarding the value, indications, and limitations of PIFU in endometrial, cervical, ovarian, and vulvar cancers in an effort to standardize practice and improve patient care." @default.
• W3016967290 created "2020-04-24" @default.
• W3016967290 creator A5001104981 @default.
• W3016967290 creator A5006958187 @default.
• W3016967290 creator A5011673236 @default.
• W3016967290 creator A5016403530 @default.
• W3016967290 creator A5020777875 @default.
• W3016967290 creator A5032434810 @default.
• W3016967290 creator A5035882742 @default.
• W3016967290 creator A5046492804 @default.
• W3016967290 creator A5051197374 @default.
• W3016967290 creator A5052036111 @default.
• W3016967290 creator A5056075088 @default.
• W3016967290 creator A5064146700 @default.
• W3016967290 creator A5064475068 @default.
• W3016967290 creator A5065502248 @default.
• W3016967290 creator A5066242060 @default.
• W3016967290 creator A5066604299 @default.
• W3016967290 creator A5071187187 @default.
• W3016967290 creator A5074801878 @default.
• W3016967290 creator A5078777241 @default.
• W3016967290 creator A5079383798 @default.
• W3016967290 creator A5086403731 @default.
• W3016967290 creator A5088485971 @default.
• W3016967290 date "2020-04-19" @default.
• W3016967290 modified "2023-10-16" @default.
• W3016967290 title "British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU)" @default.
• W3016967290 cites W1599736877 @default.
• W3016967290 cites W1966675185 @default.
• W3016967290 cites W1977293583 @default.
• W3016967290 cites W1986086825 @default.
• W3016967290 cites W1996636544 @default.
• W3016967290 cites W2020991594 @default.
• W3016967290 cites W2027745416 @default.
• W3016967290 cites W2028923601 @default.
• W3016967290 cites W2033446294 @default.
• W3016967290 cites W2074823400 @default.
• W3016967290 cites W2097772604 @default.
• W3016967290 cites W2114783818 @default.
• W3016967290 cites W2134159332 @default.
• W3016967290 cites W2156508041 @default.
• W3016967290 cites W2164316325 @default.
• W3016967290 cites W2165169035 @default.
• W3016967290 cites W2315286587 @default.
• W3016967290 cites W2331575419 @default.
• W3016967290 cites W2511267967 @default.
• W3016967290 cites W2737389832 @default.
• W3016967290 cites W2742857387 @default.
• W3016967290 cites W2772390390 @default.
• W3016967290 cites W2801283937 @default.
• W3016967290 cites W2801564336 @default.
• W3016967290 cites W2811237118 @default.
• W3016967290 cites W2963015093 @default.
• W3016967290 cites W2991500097 @default.
• W3016967290 cites W3023274953 @default.
• W3016967290 cites W4234164256 @default.
• W3016967290 cites W4254670646 @default.
• W3016967290 doi "https://doi.org/10.1136/ijgc-2019-001176" @default.
• W3016967290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32312719" @default.
• W3016967290 hasPublicationYear "2020" @default.
• W3016967290 type Work @default.
• W3016967290 sameAs 3016967290 @default.
• W3016967290 citedByCount "32" @default.
• W3016967290 countsByYear W30169672902020 @default.
• W3016967290 countsByYear W30169672902021 @default.
• W3016967290 countsByYear W30169672902022 @default.
• W3016967290 countsByYear W30169672902023 @default.
• W3016967290 crossrefType "journal-article" @default.
• W3016967290 hasAuthorship W3016967290A5001104981 @default.
• W3016967290 hasAuthorship W3016967290A5006958187 @default.
• W3016967290 hasAuthorship W3016967290A5011673236 @default.
• W3016967290 hasAuthorship W3016967290A5016403530 @default.
• W3016967290 hasAuthorship W3016967290A5020777875 @default.
• W3016967290 hasAuthorship W3016967290A5032434810 @default.
• W3016967290 hasAuthorship W3016967290A5035882742 @default.
• W3016967290 hasAuthorship W3016967290A5046492804 @default.
• W3016967290 hasAuthorship W3016967290A5051197374 @default.
• W3016967290 hasAuthorship W3016967290A5052036111 @default.
• W3016967290 hasAuthorship W3016967290A5056075088 @default.
• W3016967290 hasAuthorship W3016967290A5064146700 @default.
• W3016967290 hasAuthorship W3016967290A5064475068 @default.
• W3016967290 hasAuthorship W3016967290A5065502248 @default.
• W3016967290 hasAuthorship W3016967290A5066242060 @default.
• W3016967290 hasAuthorship W3016967290A5066604299 @default.
• W3016967290 hasAuthorship W3016967290A5071187187 @default.
• W3016967290 hasAuthorship W3016967290A5074801878 @default.
• W3016967290 hasAuthorship W3016967290A5078777241 @default.
• W3016967290 hasAuthorship W3016967290A5079383798 @default.
• W3016967290 hasAuthorship W3016967290A5086403731 @default.
• W3016967290 hasAuthorship W3016967290A5088485971 @default.
• W3016967290 hasBestOaLocation W30169672902 @default.
• W3016967290 hasConcept C121608353 @default.
• W3016967290 hasConcept C126322002 @default.
• W3016967290 hasConcept C136264566 @default.
• W3016967290 hasConcept C141071460 @default.
• W3016967290 hasConcept C162324750 @default.
• W3016967290 hasConcept C168563851 @default.
• W3016967290 hasConcept C172400760 @default.

• next